ANVS   $6.78  3.67% Market Closed

Annovis Bio Inc
Total Cash 4.00M
totalCashPerShare 0.306
EBITDA
Total Debt 0.00
quickRatio 0.985
currentRatio 1.244
Total Revenue
debtToEquity
Revenue/Share
ROA -1.8338901
ROE -4.53011
grossProfits
freeCashflow -14.05M
operatingCashflow -29.14M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 108.01M
forwardPE -4.7403316
floatShares 10.24M
sharesOutstanding 13.05M
sharesShort 1.36M
sharesShortPriorMonth 1.20M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.22%
heldPercentInstitutions 0.08%
Short Ratio help_outline 5.96%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue -0.149
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -43.02M
trailingEps -4.68%
forwardEps -1.81%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.53 3Q 2024
institutionsCount 36
lastUpdated Nov. 7, 2024, 7:10 a.m.